Engineered blood and lymphatic capillaries in 3-D VEGF-fibrin-collagen matrices with interstitial flow

Biotechnology and Bioengineering

Volumn 96, Issue 1, 2007, Pages 167-176

  Helm, Cara Lynn E ^a   Zisch, Andreas ^b   Swartz, Melody A ^a,c  

^a Northwestern University   (United States)

^b UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^c EPFL   (Switzerland)

Author keywords

Angiogenesis; In vitro; Lymphangiogenesis; Protease; Tissue engineering; Vasculogenesis

Indexed keywords

BLOOD; CAPILLARY FLOW; CELLS; ENZYMES; MATRIX ALGEBRA; OPTIMIZATION;

ANGIOGENESIS; IN VITRO; LYMPHANGIOGENESIS; PROTEASE; TISSUE ENGINEERING; VASCULOGENESIS;

COLLAGEN;

COLLAGEN; FIBRIN; PROTEINASE; VASCULOTROPIN;

ANGIOGENESIS; ARTICLE; CAPILLARY; COMPLIANCE (PHYSICAL); CONCENTRATION (PARAMETERS); CONTROLLED STUDY; COVALENT BOND; ENDOTHELIUM CELL; FLUID FLOW; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; INTERSTITIAL FLUID; LYMPHANGIOGENESIS; MORPHOGENESIS; TISSUE ENGINEERING; VASCULARIZATION;

CAPILLARIES; CELL CULTURE TECHNIQUES; CELL DIFFERENTIATION; CELL PROLIFERATION; CELLS, CULTURED; COLLAGEN; ENDOTHELIAL CELLS; EXTRACELLULAR MATRIX; EXTRACELLULAR MATRIX PROTEINS; FIBRIN; HUMANS; LYMPHATIC VESSELS; NEOVASCULARIZATION, PHYSIOLOGIC; TISSUE ENGINEERING; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 33845874118     PISSN: 00063592     EISSN: 10970290     Source Type: Journal    
DOI: 10.1002/bit.21185     Document Type: Article

References (53)

1. Albelda SM, Daise M, Levine EM, Buck CA. 1989. Identification and characterization of cell-substratum adhesion receptors on cultured human endothelial cells. J Clin Invest 83(6): 1992-2002.
2. Bini A, Wu D, Schnuer J, Kudryk BJ. 1999. Characterization of stromelysin 1 (MMP-3), matrilysin (MMP-7), and membrane type 1 matrix metalloproteinase (MT1-MMP) derived fibrin(ogen) fragments D-dimer and D-like monomer: NH2-terminal sequences of late-stage digest fragments. Biochemistry 38(42):13928-13936.
3. Black AF, Berthod F, L'Heureux N, Germain L, Auger FA. 1998. In vitro reconstruction of a human capillary-like network in a tissue-engineered skin equivalent. FASEB J 12(13):1331-1340.
4. Boardman KC, Swartz MA. 2003. Interstitial fluid flow as a guide for lymphangiogenesis. Circ Res 92:801-808.
5. Boudreau NJ, Jones PL. 1999. Extracellular matrix and integrin signalling: The shape of things to come. Biochem J 339(Pt 3):481-488.
6. Brooks PC, Clark RA, Cheresh DA. 1994. Requirement of vascular integrin alpha v beta 3 for angiogenesis. Science 264(5158):569-571.
7. Cassell OC, Hofer SO, Morrison WA, Knight KR. 2002. Vascularisation of tissue-engineered grafts: The regulation of angiogenesis in reconstructive surgery and in disease states. Br J Plast Surg 55(8):603-610.
8. Chary SR, Jain RK. 1989. Direct measurement of interstitial convection and diffusion of albumin in normal and neoplastic tissues by fluorescence photobleaching. Proc Natl Acad Sci USA 86(14):5385-5389.
9. Chavakis T, Cines DB, Rhee JS, Liang OD, Schubert U, Hammes HP, Higazi AA, Nawroth PP, Preissner KT, Bdeir K. 2004. Regulation of neovascularization by human neutrophil peptides (alpha-defensins): A link between inflammation and angiogenesis. FASEB J 18(11):1306-1308.
10. Clark RA, Nielsen LD, Welch MP, McPherson JM. 1995. Collagen matrices attenuate the collagen-synthetic response of cultured fibroblasts to TGF-beta. J Cell Sci 108(Pt 3):1251-1261.
11. Dafni H, Israely T, Bhujwalla ZM, Benjamin LE, Neeman M. 2002. Overexpression of vascular endothelial growth factor 165 drives peritumor interstitial convection and induces lymphatic drain: Magnetic resonance imaging, confocal microscopy, and histological tracking of triple-labeled albumin. Cancer Res 62(22):6731-6739.
12. Davis GE, Bayless KJ, Mavila A. 2002. Molecular basis of endothelial cell morphogenesis in three-dimensional extracellular matrices. Anat Rec 268(3):252-275.
13. Dike LE, Chen CS, Mrksich M, Tien J, Whitesides GM, Ingber DE. 1999. Geometric control of switching between growth, apoptosis, and differentiation during angiogenesis using micropatterned substrates. In Vitro Cell Dev Biol Anim 35(8):441-448.
14. Egginton S, Gerritsen M. 2003. Lumen formation: In vivo versus in vitro observations. Microcirculation 10(1):45-61.
15. Ehrbar M, Djonov VG, Schnell C, Tschanz SA, Martiny-Baron G, Schenk U, Wood J, Burri PH, Hubbell JA, Zisch AH. 2004. Cell-demanded liberation of VEGF121 from fibrin implants induces local and controlled blood vessel growth. Circ Res 94(8):1124-1132.
16. Ehrbar M, Metters A, Zammaretti P, Hubbell JA, Zisch AH. 2005. Endothelial cell proliferation and progenitor maturation by fibrin-bound VEGF variants with differential susceptibilities to local cellular activity. J Control Release 101(1-3):93-109.
17. Fairbrother WJ, Champe MA, Christinger HW, Keyt BA, Starovasnik MA. 1998. Solution structure of the heparin-binding domain of vascular endothelial growth factor. Structure 6(5):637-648.
18. Fannon M, Forsten KE, Nugent MA. 2000. Potentiation and inhibition of bFGF binding by heparin: A model for regulation of cellular response. Biochemistry 39(6):1434-1445.
19. Feng X, Clark RA, Galanakis D, Tonnesen MG. 1999. Fibrin and collagen differentially regulate human dermal microvascular endothelial cell integrins: Stabilization of alphav/beta3 mRNA by fibrin1. J Invest Dermatol 113(6):913-919.
20. Ferrara N, Gerber HP, LeCouter J. 2003. The biology of VEGF and its receptors. Nat Med 9(6):669-676.
21. Fleury ME, Boardman KC, Swartz MA. 2006. Autologous morphogen gradients by subtle interstitial flow and matrix interactions. Biophys J 91(1):113-121.
22. Griffith LG, Swartz MA. 2006. Capturing complex 3D tissue physiology in vitro. Nat Rev Mol Cell Biol 7(3):211-224.
23. Haas TL. 2005. Endothelial cell regulation of matrix metalloproteinases. Can J Physiol Pharmacol 83(1):1-7.
24. Hall H, Hubbell JA. 2004. Matrix-bound sixth Ig-like domain of cell adhesion molecule L1 acts as an angiogenic factor by ligating alphavbeta3-integrin and activating VEGF-R2. Microvasc Res 68(3): 169-178.
25. Helm CE, Fleury ME, Zisch AH, Boschetti F, Swartz MA. 2005. Synergy between interstitial flow and VEGF directs capillary morphogenesis in vitro through a gradient amplification mechanism. Proc Natl Acad Sci USA 102(44):15779-15784.
26. Herbert CB, Nagaswami C, Bittner GD, Hubbell JA, Weisel JW. 1998. Effects of fibrin micromorphology on neurite growth from dorsal root ganglia cultured in three-dimensional fibrin gels. J Biomed Mater Res 40(4):551-559.
27. Herrick S, Blanc-Brude O, Gray A, Laurent G. 1999. Fibrinogen. Int J Biochem Cell Biol 31(7):741-746.
28. Hudon V, Berthod F, Black AF, Damour O, Germain L, Auger FA. 2003. A tissue-engineered endothelialized dermis to study the modulation of angiogenic and angiostatic molecules on capillary-like tube formation in vitro. Br J Dermatol 148(6):1094-1104.
29. Jain RK, Au P, Tam J, Duda DG, Fukumura D. 2005. Engineering vascularized tissue. Nat Biotechnol 23:821-823.
30. Jalali S, del Pozo MA, Chen K, Miao H, Li Y, Schwartz MA, Shyy JY, Chien S. 2001. Integrin-mediated mechanotransduction requires its dynamic interaction with specific extracellular matrix (ECM) ligands. Proc Natl Acad Sci USA 98(3):1042-1046.
31. Keyt BA, Berleau LT, Nguyen HV, Chen H, Heinsohn H, Vandlen R, Ferrara N. 1996. The carboxyl-terminal domain (111-165) of vascular endothelial growth factor is critical for its mitogenic potency. J Biol Chem 271(13):7788-7795.
32. Levenberg S, Rouwkema J, Macdonald M, Garfein ES, Kohane DS, Darland DC, Marini R, van Blitterswijk CA, Mulligan RC, D'Amore PA, et al. 2005. Engineering vascularized skeletal muscle tissue [see comment]. Nat Biotechnol 23(7):879-884.
33. Nehls V, Herrmann R. 1996. The configuration of fibrin clots determines capillary morphogenesis and endothelial cell migration. Microvasc Res 1(3):347-364.
34. Ng CP, Swartz MA. 2003. Fibroblast alignment under interstitial fluid flow using a novel 3-D tissue culture model. Am J Physiol 284(5):H1771-1777.
35. Ng CP, Helm CL, Swartz MA. 2004. Interstitial flow differentially stimulates blood and lymphatic endothelial cell morphogenesis in vitro. Microvasc Res 68(3):258-264.
36. Ng CP, Hinz B, Swartz MA. 2005. Interstitial fluid flow induces myofibroblast differentiation and collagen alignment in vitro. J Cell Sci 118(Pt 20):4731-4739.
37. Nguyen M, Arkell J, Jackson CJ. 2001. Human endothelial gelatinases and angiogenesis. Int J Biochem Cell Biol 33(10):960-970.
38. Pedersen JA, Swartz MA. 2005. Mechanobiology in the third dimension. Ann Biomed Eng 33(11):1469-1490.
39. Pepper MS. 2001. Role of the matrix metalloproteinase and plasminogen activator-plasmin systems in angiogenesis. Arterioscler, Thromb Vasc Biol 21(7):1104-1117.
40. Pepper MS, Montesano R, Mandriota SJ, Orci L, Vassalli JD. 1996. Angiogenesis: A paradigm for balanced extracellular proteolysis during cell migration and morphogenesis. Enzyme Protein 49(1-3) 138-162.
41. Podgrabinska S, Braun P, Velasco P, Kloos B, Pepper MS, Jackson DG, Skobe M. 2002. Molecular characterization of lymphatic endothelial cells. Proc Natl Acad Sci USA 99(25):16069-16074.
42. Richardson TP, Peters MC, Ennett AB, Mooney DJ. 2001. Polymeric system for dual growth factor delivery [comment]. Nat Biotechnol 19(11): 1029-1034.
43. Rutkowski JM, Boardman KC, Swartz MA. 2006. Characterization of lymphangiogenesis in a model of adult skin regeneration. Am J Physiol Heart Circ Physiol 291(3):H1402-H1410.
44. Ryan EA, Mockros LF, Weisel JW, Lorand L. 1999. Structural origins of fibrin clot rheology. Biophys J 77(5):2813-2826.
45. Singer AJ, Clark RA. 1999. Cutaneous wound healing. N Engl J Med 341(10):738-746.
46. Sjoland JA. 2005. A new optimized method for the determination of fibrin clot permeability. Blood Coagul Fibrinolysis 16(8):579-583.
47. Tremblay PL, Hudon V, Berthod F, Germain L, Auger FA. 2005. Inosculation of tissue-engineered capillaries with the host's vasculature in a reconstructed skin transplanted on mice. Am J Transplant 5(5):1002-1010.
48. Urech L, Bittermann A, Hubbell J, Hall H. 2005. Mechanical properties, proteolytic degradability and biological modifications affect angiogenic process extension into native and modified fibrin matrices in vitro. Biomaterials 26:1369-1379.
49. Vailhe B, Lecomte M, Wiernsperger N, Tranqui L. 1998. The formation of tubular structures by endothelial cells is under the control of fibrinolysis and mechanical factors. Angiogenesis 2(4):331-344.
50. Vailhe B, Vittet D, Feige JJ. 2001. In vitro models of vasculogenesis and angiogenesis. Lab Invest 81(4):439-452.
51. van Hinsbergh VW, Collen A, Koolwijk P. 2001. Role of fibrin matrix in angiogenesis. Ann NY Acad Sci 936:426-437.
52. Zisch AH, Schenk U, Schense JC, Sakiyama-Elbert SE, Hubbell JA. 2001. Covalently conjugated VEGF-fibrin matrices for endothelialization. J Control Release 72(1-3):101-113.
53. Zisch AH, Lutolf MP, Ehrbar M, Raeber GP, Rizzi SC, Davies N, Schmokel H, Bezuidenhout D, Djonov V, Zilla P, et al. 2003. Cell-demanded release of VEGF from synthetic, biointeractive cell ingrowth matrices for vascularized tissue growth. FASEB J 17(15):2260-2262.